Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Change in Inventory (2021 - 2025)

Mirum Pharmaceuticals has reported Change in Inventory over the past 5 years, most recently at $2.3 million for Q4 2025.

  • Quarterly results put Change in Inventory at $2.3 million for Q4 2025, up 966.36% from a year ago — trailing twelve months through Dec 2025 was $8.4 million (up 166.84% YoY), and the annual figure for FY2025 was $8.4 million, up 166.84%.
  • Change in Inventory for Q4 2025 was $2.3 million at Mirum Pharmaceuticals, up from $1.2 million in the prior quarter.
  • Over the last five years, Change in Inventory for MIRM hit a ceiling of $2.8 million in Q3 2022 and a floor of -$1.2 million in Q4 2023.
  • Median Change in Inventory over the past 5 years was $964000.0 (2024), compared with a mean of $972411.8.
  • Biggest five-year swings in Change in Inventory: plummeted 220.81% in 2022 and later soared 1061.19% in 2023.
  • Mirum Pharmaceuticals' Change in Inventory stood at $495000.0 in 2021, then plummeted by 220.81% to -$598000.0 in 2022, then crashed by 106.02% to -$1.2 million in 2023, then soared by 117.37% to $214000.0 in 2024, then soared by 966.36% to $2.3 million in 2025.
  • The last three reported values for Change in Inventory were $2.3 million (Q4 2025), $1.2 million (Q3 2025), and $2.3 million (Q2 2025) per Business Quant data.